English Summary - Use of the prostate-specific antigen (PSA) test in prostate cancer screening in Quebec (report)

L’os étant le site métastatique le plus fréquent chez les patients atteints d’un cancer de la prostate, de nombreux essais cliniques ont évalué l’utilisation de

The use of the PSA screening test could well explain the increase in the number of prostate cancer hospitalizations in men aged 50 to 69 years over the past 30 years. It also

Data from the European Randomised Study of Screening for Prostate Cancer (ERSPC) are used here to show the balance between the potential risks and benefits associated with the

The objectives of this study are to quantify changes in PSA testing in Ontario males aged 35 or older from 2003 to 2012, and to study the associa- tion of selected factors,

Of the 57 men considered in the study, 54 (95%) believed that using the PSA blood test as a screening tool for prostate cancer was not risky, 39 (68%) believed that the PSA blood

Given that my father had incidental prostate cancer later in his life, and considering myself to be at some increased risk, I enrolled in the multicentre

• The number of new prostate cancer cases and deaths will almost double by 2030 in Latin America and the Caribbean if current trends continue.. Proportion of new cases

 ere is little doubt that PSA can detect prostate cancer. A study of 22 071 healthy men aged 40 to 82 years who had serum stored at baseline showed that 366 developed